Off-label use of the Sapien and Sapien XT valves represents a “viable and durable option” for restoring pulmonary valve function in patients with right-ventricular outflow tract (RVOT) disorders, ...

DUBLIN, May 15, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (MDT) today announced results from two late-breaking clinical trials presented virtually at the 2020 Society for Cardiovascular Angiography and ...

July 23, 2009 (Gaithersburg, Maryland) — The FDA Circulatory System Devices Panel voted 12 to 0 to recommend approval of a transcatheter pulmonary valve for use under humanitarian device exemption ...

Most patients who undergo percutaneous pulmonary valve implantation for right ventricular outflow tract (RVOT) dysfunction achieve acute hemodynamic benefit within 1 month that is sustained out to at ...

Researchers have found a way to take a pediatric patient’s skin cells, reprogram the skin cells to function as heart valvular cells, and then use the cells as part of a tissue-engineered pulmonary ...

Biventricular correction of tetralogy of Fallot was devised more than 50 years ago. Current short-term outcomes are excellent. The potential for late complications is, however, an important concern ...

Ten-year outcomes from the Melody Transcatheter Pulmonary Valve (TPV) Therapy demonstrated strong long-term hemodynamic and safety outcomes, while the first-ever results from the investigational ...